NIPRO CORP

NIPRO CORP Share · JP3673600007 · 875746 (XTKS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NIPRO CORP
No Price
Closing Price XTKS 01.05.2026: 1.494,00 JPY
01.05.2026 05:42
Current Prices from NIPRO CORP
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
8086.T
JPY
01.05.2026 05:42
1.494,00 JPY
-25,00 JPY
-1,65 %
OTC: UTC
UTC
NPRRF
USD
30.04.2026 20:00
9,96 USD
0,00 USD
XDUS: Düsseldorf
Düsseldorf
NCRSN07.DUSB
EUR
30.04.2026 14:00
8,05 EUR
-
XDQU: Quotrix
Quotrix
NCRSN07.DUSD
EUR
30.04.2026 05:27
8,15 EUR
-
Share Float & Liquidity
Free Float 88,89 %
Shares Float 144,98 M
Shares Outstanding 163,1 M
Invested Funds

The following funds have invested in NIPRO CORP:

Fund
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)
Vol. in million
67,39
Percentage (%)
0,04 %
Fund
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged (Acc)
Vol. in million
27,53
Percentage (%)
0,04 %
Company Profile for NIPRO CORP Share
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

Company Data

Name NIPRO CORP
Company Nipro Corporation
Website https://www.nipro.co.jp
Primary Exchange XTKS Tokyo
WKN 875746
ISIN JP3673600007
Asset Class Share
Sector Healthcare
Industry Medical - Instruments & Supplies
CEO Yoshihiko Sano
Market Capitalization 2 Mrd.
Country Japan
Currency EUR
Employees 38,1 T
Address 3-9-3 Honjo-nishi, 531-8510 Osaka
IPO Date 2001-01-01
Dividends from 'NIPRO CORP'
Ex-Date Dividend per Share
30.03.2026 14,34 JPY
29.09.2025 10,00 JPY
28.03.2025 20,00 JPY
27.09.2024 12,00 JPY
28.03.2024 15,00 JPY
28.09.2023 10,00 JPY
30.03.2023 8,50 JPY
29.09.2022 13,50 JPY
30.03.2022 14,50 JPY
29.09.2021 14,50 JPY

Stock Splits

Date Split
28.09.2011 2:1

Ticker Symbols

Name Symbol
Over The Counter NPRRF
Düsseldorf NCRSN07.DUSB
Frankfurt 5FA.F
Quotrix NCRSN07.DUSD
Tokyo 8086.T
More Shares
Investors who hold NIPRO CORP also have the following shares in their portfolio:
FLA PWR LT 2038
FLA PWR LT 2038 Bond
LBBW       HPF 11/21 MTN
LBBW HPF 11/21 MTN Bond